Cognitive performance in patients with neuromyelitis optica: clinical and imaging characteristics-Reference-Cited by-同舟云学术

Cognitive performance in patients with neuromyelitis optica: clinical and imaging characteristics

Published:2024-08-30 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Apiraksattayakul Natnasak,Lerttanatum Chompoonuch,Maethasith Inthiporn,Wongsripuemtet Jitsupa,Siritho Sasitorn,Jitprapaikulsarn Jiraporn,Ongphichetmetha Tatchaporn,Prayoonwiwat Naraporn,Senanarong Vorapun,Rattanabannakit Chatchawan

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-71176-x.pdf

Reference40 articles.

1. Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85, 177–189. https://doi.org/10.1212/wnl.0000000000001729 (2015).

2. Siritho, S., Nakashima, I., Takahashi, T., Fujihara, K. & Prayoonwiwat, N. AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems. Neurology 77, 827–834. https://doi.org/10.1212/WNL.0b013e31822c61b1 (2011).

3. Liu, Y. et al. Structural MRI substrates of cognitive impairment in neuromyelitis optica. Neurology 85, 1491–1499. https://doi.org/10.1212/wnl.0000000000002067 (2015).

4. Tisavipat, N. et al. The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study. Mult. Scler Relat. Disord. 70, 104511. https://doi.org/10.1016/j.msard.2023.104511 (2023).

5. Moore, P. et al. Cognitive and psychiatric comorbidities in neuromyelitis optica. J. Neurol. Sci. 360, 4–9. https://doi.org/10.1016/j.jns.2015.11.031 (2016).